| |
| |
|
| Insider
Information: |
Tyree James L |
| Relationship: |
Director |
| City: |
Abbott Park |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
286,780 |
|
|
Indirect Shares
|
1,199 |
|
|
| Direct
Value |
$14,978,033 |
|
|
|
Indirect Value
|
$124,708 |
|
|
| Total
Shares |
287,979 |
|
|
| Total
Value |
$15,102,741 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -70.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Abbott Laboratories |
ABT |
Executive Vice President |
2009-02-27 |
132,176 |
2009-02-27 |
1,199 |
Premium* |
|
|
Innoviva Inc |
INVA |
Director |
2017-04-20 |
70,554 |
2014-06-02 |
0 |
Premium* |
|
|
Chemocentryx, Inc. |
CCXI |
Director |
2022-10-20 |
0 |
2015-05-22 |
0 |
Premium* |
|
|
Assertio Holdings Inc |
ASRT |
Director |
2019-05-08 |
80,590 |
2019-05-07 |
0 |
Premium* |
|
|
Genelux Corp |
GNLX |
Director |
2023-12-13 |
3,460 |
2023-02-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-02-16 |
4 |
A |
$52.54 |
$1,964,996 |
D/D |
37,400 |
123,005 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-02-17 |
4 |
D |
$52.49 |
$182,980 |
D/D |
(3,486) |
119,519 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-02-18 |
4 |
D |
$52.49 |
$35,851 |
D/D |
(683) |
118,836 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-02-20 |
4 |
D |
$52.49 |
$93,222 |
D/D |
(1,776) |
117,060 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-02-20 |
4 |
D |
$52.49 |
$1,175,146 |
D/D |
(22,388) |
120,470 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-02-20 |
4 |
OE |
$41.03 |
$1,058,536 |
D/D |
25,798 |
142,858 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-05-01 |
4 |
D |
$56.62 |
$30,575 |
D/D |
(540) |
119,930 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-06-01 |
4 |
OE |
$41.14 |
$1,641,811 |
D/D |
34,797 |
154,727 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-06-01 |
4 |
S |
$56.62 |
$2,725,328 |
D/D |
(48,130) |
106,597 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-06-30 |
4 |
D |
$53.55 |
$211,255 |
D/D |
(3,945) |
102,652 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-08-22 |
4 |
OE |
$40.93 |
$983,029 |
D/D |
23,891 |
126,543 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-08-22 |
4 |
D |
$52.36 |
$1,077,778 |
D/D |
(20,584) |
105,959 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice PresidentOfficer |
• – – |
2005-04-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
52,503 |
|
- |
|
| ABT |
Abbott Laboratories |
Senior Vice PresidentOfficer |
• – – |
2005-04-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,087 |
|
- |
|
89 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
